{"id":"https://openalex.org/W4393085751","doi":"https://doi.org/10.1158/1538-7445.am2024-4190","title":"Abstract 4190: Patient-derived xenograft (PDX) models with differential HER2 expression for preclinical evaluation of HER2-targeted therapies","display_name":"Abstract 4190: Patient-derived xenograft (PDX) models with differential HER2 expression for preclinical evaluation of HER2-targeted therapies","alternate_titles":[],"publication_year":2024,"publication_date":"2024-03-22","ids":{"openalex":"https://openalex.org/W4393085751","doi":"https://doi.org/10.1158/1538-7445.am2024-4190"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2024-4190","doi":"https://doi.org/10.1158/1538-7445.am2024-4190","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2024-4190","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4393085751"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102371525","display_name":"Xiaoliu Yang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiaoliu Yang","raw_affiliation_strings":["1Gempharmatech Co., Ltd., Nanjing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Gempharmatech Co., Ltd., Nanjing, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109298284","display_name":"Shiying Guo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shiying Guo","raw_affiliation_strings":["1Gempharmatech Co., Ltd., Nanjing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Gempharmatech Co., Ltd., Nanjing, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004038183","display_name":"Huiyi Wang","orcid":"https://orcid.org/0009-0007-6121-4175","observed_orcids":["https://orcid.org/0009-0007-6121-4175","https://orcid.org/0009-0007-3065-4071"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Huiyi Wang","raw_affiliation_strings":["1Gempharmatech Co., Ltd., Nanjing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Gempharmatech Co., Ltd., Nanjing, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100991332","display_name":"Xu Su","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xu Su","raw_affiliation_strings":["1Gempharmatech Co., Ltd., Nanjing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Gempharmatech Co., Ltd., Nanjing, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066194861","display_name":"Jing Zhao","orcid":"https://orcid.org/0000-0002-1198-0556","observed_orcids":["https://orcid.org/0000-0002-1198-0556"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jing Zhao","raw_affiliation_strings":["1Gempharmatech Co., Ltd., Nanjing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Gempharmatech Co., Ltd., Nanjing, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100328685","display_name":"Xiangyu Gao","orcid":"https://orcid.org/0000-0002-1697-1157","observed_orcids":["https://orcid.org/0000-0002-1697-1157"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiang Gao","raw_affiliation_strings":["1Gempharmatech Co., Ltd., Nanjing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Gempharmatech Co., Ltd., Nanjing, China","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5003931681","display_name":"Cunxiang Ju","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cunxiang Ju","raw_affiliation_strings":["1Gempharmatech Co., Ltd., Nanjing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Gempharmatech Co., Ltd., Nanjing, China","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"84","issue":"6_Supplement","first_page":"4190","last_page":"4190"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9496999979019165,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9496999979019165,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.04749999940395355,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/her2","display_name":"HER2","score":0.7919999957084656},{"id":"https://openalex.org/keywords/gastric-cancer","display_name":"gastric cancer","score":0.9789999723434448},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.9279999732971191},{"id":"https://openalex.org/keywords/her2-targeted-therapy","display_name":"HER2-targeted therapy","score":0.9449999928474426},{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/margetuximab","display_name":"margetuximab","score":0.9869999885559082},{"id":"https://openalex.org/keywords/trastuzumab-deruxtecan","display_name":"trastuzumab deruxtecan","score":0.8220000267028809},{"id":"https://openalex.org/keywords/drug-response","display_name":"drug response","score":0.5680000185966492},{"id":"https://openalex.org/keywords/personalized-treatment","display_name":"personalized treatment","score":0.5830000042915344}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5737614035606384},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5122932195663452}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2024-4190","doi":"https://doi.org/10.1158/1538-7445.am2024-4190","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2024-4190","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4401511189","https://openalex.org/W4404052973","https://openalex.org/W2777578829","https://openalex.org/W2600505732","https://openalex.org/W2739586988","https://openalex.org/W1630649393","https://openalex.org/W2027923643","https://openalex.org/W2741799509","https://openalex.org/W2885652137","https://openalex.org/W2806564245"],"abstract_inverted_index":{"Abstract":[0],"Human":[1],"epidermal":[2],"growth":[3],"factor":[4],"receptor":[5],"2":[6],"(HER2)":[7],"is":[8],"a":[9,26,40,50,62,141,164],"critical":[10],"therapeutic":[11,120],"target":[12],"in":[13,23,29,96],"gastric":[14,57,172],"cancer.":[15],"However,":[16],"the":[17,31,91,97,108,114,118,124,155,209],"varying":[18,92],"expression":[19,67,94,110,138,198],"levels":[20,95,139],"of":[21,52,65,116,127,132,147,158,202,208],"HER2":[22,66,93,109,125,137,159,197],"patients":[24],"present":[25],"significant":[27],"challenge":[28,157],"selecting":[30,117],"appropriate":[32],"HER2-targeted":[33,75,148,203],"therapies.":[34,149],"Patient-derived":[35,191],"xenograft":[36,192],"(PDX)":[37,193],"models":[38,54,70,134,194],"offer":[39],"valuable":[41],"tool":[42],"to":[43,90],"address":[44],"this":[45],"clinical":[46,156],"concern.":[47],"We":[48],"established":[49],"panel":[51],"PDX":[53,98,133],"derived":[55],"from":[56],"cancer":[58,173],"patients,":[59],"each":[60],"representing":[61],"distinct":[63,105],"range":[64],"levels.":[68],"These":[69],"were":[71],"subsequently":[72],"treated":[73],"with":[74,135,195],"drugs,":[76],"including":[77],"Trastuzumab":[78],"(Herceptin),":[79],"Margetuximab,":[80,101],"and":[81,102,167],"Enhertu.":[82],"Our":[83,130],"results":[84],"demonstrated":[85],"differential":[86,136,196],"drug":[87],"responses":[88],"corresponding":[89],"samples.":[99],"Trastuzumab,":[100],"Enhertu":[103],"exhibited":[104],"efficacies":[106],"across":[107],"spectrum.":[111],"This":[112,150],"underscores":[113],"significance":[115],"right":[119],"approach":[121,151],"based":[122],"on":[123],"status":[126],"individual":[128],"patient.":[129],"collection":[131],"provides":[140],"robust":[142],"platform":[143],"for":[144,171,199,212],"preclinical":[145,200],"evaluation":[146,201],"not":[152],"only":[153],"addresses":[154],"heterogeneity":[160],"but":[161],"also":[162],"facilitates":[163],"more":[165],"personalized":[166],"effective":[168],"treatment":[169],"strategy":[170],"patients.":[174],"Citation":[175],"Format:":[176],"Xiaoliu":[177],"Yang,":[178],"Shiying":[179],"Guo,":[180],"Huiyi":[181],"Wang,":[182],"Xu":[183],"Su,":[184],"Jing":[185],"Zhao,":[186],"Xiang":[187],"Gao,":[188],"Cunxiang":[189],"Ju.":[190],"therapies":[204],"[abstract].":[205],"In:":[206],"Proceedings":[207],"American":[210],"Association":[211],"Cancer":[213,231],"Research":[214],"Annual":[215],"Meeting":[216],"2024;":[217],"Part":[218],"1":[219],"(Regular":[220],"Abstracts);":[221],"2024":[222],"Apr":[223],"5-10;":[224],"San":[225],"Diego,":[226],"CA.":[227],"Philadelphia":[228],"(PA):":[229],"AACR;":[230],"Res":[232],"2024;84(6_Suppl):Abstract":[233],"nr":[234],"4190.":[235]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4393085751","counts_by_year":[],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2024-03-23T00:00:00"}
